TRANSLATIONAL SCIENCES INC.

Company Information
Address 1840 OVERTON PARK AVE
MEMPHIS, TN, 38112-5410


Information

DUNS: 803592364

# of Employees: 0


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. HLS Potent, novel inhibitor of fibrinolytic hemorrhage

    Amount: $351,119.00

    This SBIR Application is responsive to NHLBI Small Business Topics of Special Interest therapeutics that are of high programmatic interest HL Hemorrhage or bleeding is a serious or fatal c ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  2. Novel Methods for Dissolving Blood Clots

    Amount: $1,005,000.00

    DESCRIPTION provided by applicant Each year venous thromboembolism VTE affects up to million Americans and million people worldwide VTE patients have blood clots in the legs venous thrombo ...

    SBIRPhase II2015Department of Health and Human Services National Institutes of Health
  3. Reducing Stroke by a Novel, Clot-dissolving Antibody

    Amount: $2,999,979.00

    DESCRIPTION (provided by applicant): Stroke is the 3rd leading cause of death and the primary cause of severe, long term disability. Each year 795,000 Americans have a stroke and the annual costs to ...

    SBIRPhase II2012Department of Health and Human Services
  4. Novel Methods for Dissolving Blood Clots

    Amount: $1,519,440.00

    DESCRIPTION (provided by applicant): Each year, as many as 2 million Americans develop venous thromboembolism (VTE). VTEs are blood clots in the legs (venous thrombosis) that may travel to the lungs ( ...

    STTRPhase II2012Department of Health and Human Services
  5. Reducing Stroke by a Novel, Clot-dissolving Antibody

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): Stroke is the 3rd leading cause of death and the primary cause of severe, long term disability. Each year 795,000 Americans have a stroke and the annual costs to ...

    SBIRPhase I2011Department of Health and Human Services
  6. Novel Methods for Dissolving Blood Clots

    Amount: $167,685.00

    DESCRIPTION (provided by applicant): Cardiovascular disease is the leading cause of death worldwide. Current therapies for cardiovascular disease are associated with partial success, restricted access ...

    STTRPhase I2010Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government